U.S. Healthcare: Twist in Fate

By CIOReview | Friday, November 2, 2018

Technology has changed the game in many industries over the last decade, transforming the focus away from traditional methods of performing all functions. Without having any discrimination, all kinds of companies have been forced to implement various AI (Artificial Intelligence) applications with the help of advanced softwares, hardware, and an ever-connected network through the internet. Finance, transportation, e-commerce, and healthcare can be considered the industries highly impacted by AI.

In the past few years, the healthcare in the U.S. was pretty dark in its several areas. More than 12 millions of errors in function, reduced life expectancy, and increased depression and suicide rate are continuously following the healthcare industry and these problems are creating noticeable fluctuations in the U.S. economy. So the govt, as well as the healthcare organizations, are more focusing on the healthcare aspects of people in the country by utilizing various advantages of the AI and machine learning. AI reduces complexity of some medical functions and makes them much easier to perform, such as wearable sensor physiology, scan anatomy (above), DNA sequencing, and gut microbiome biology.

AI-powered technologies have provided various new approaches and new processes to the medical industry such as radiology scan reading technology, identifying tumours, and tracking the spread of cancer through new technological experiments, eye conditions detection using retinal imaging technology, and “bloodless blood test”.

American companies like BERG, AstraZeneca and, London-based Exscientia are intending to integrate and harmonize the power of AI into various operations. BERG has partnered with various drug manufacturers like AstraZeneca and Sanofi Pasteur with an intention to find a new cure for Parkinson’s disease by implementing AI and Machine learning. Another case that is widely discussed is that the Virta Health CEO Sami Inkinen has given a new way of delivering care for the diabetes patients. They have provided digitally connected devices to measure blood pressure, blood sugar, ketones, and weight. Sugar.IQ, an app developed by IBM Watson has also provided the same functions as of Virta.

AI in the U.S. healthcare, as a medicine-making tool is still in its beginning stages. But the usage of AI platforms have promisingly shown their wide range of benefits like time and cost savings,  accuracy in function, clarity in data, and efficiency in workflow.